Litcius/Paper detail

CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC

Jose M. Pacheco, Erin L. Schenk

2021Journal of Thoracic Oncology10 citationsDOI

Topics & Concepts

MedicineAdenosineCancer researchAdenosine receptorPharmacologyReceptorInternal medicineAgonistLung Cancer Treatments and MutationsRadiopharmaceutical Chemistry and ApplicationsLung Cancer Research Studies
CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC | Litcius